To minimize impacts on patient care associated with drug shortages, PBMs are leading crossindustry collaboration, including with pharmaceutical manufacturers, pharmacies, hospitals, and health plans, to facilitate Americans’ continued access to a safe, effective, and reliable supply of prescription drugs. If a shortage or supply disruption for a specific medication does occur, PBMs will work with the patient, their prescriber, and their health plan to identify a covered therapeutic substitute and help minimize patient impact caused by a shortage.

To avoid worsening any potential shortages or supply disruptions, not only of medications to treat COVID-19 but other essential prescription drugs, PCMA recommends federal, state, and local government leaders:

To find out more on what PBMs are doing, click here